NCT04564898 2026-01-08TriComBGruppo Oncologico del Nord-OvestPhase 1/2 Active not recruiting48 enrolled
NCT04940546 2024-12-03Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM PatientsSun Yat-sen UniversityPhase 1/2 Active not recruiting36 enrolled